Matthew Bernard, PhD - Research Scientist
Dr. Bernard has extensive knowledge in designing and conducting applied research studies in immunopharmacology and immunotoxicology in a GLP environment. He has specialized in immunoassay development, validation, and implementation for pharmacology and toxicology endpoints, including over a decade of flow cytometry experience.
He received his degree in Microbiology & Immunology from the University of Rochester and continued his training as a postdoctoral fellow at the La Jolla Institute for Allergy & Immunology. As a Senior Research Investigator at Bristol-Myers Squibb, he worked in Drug Safety Evaluation performing investigative research for small molecule and biotherapeutic toxicology. Dr. Bernard's role in the In Vivo Facility includes custom model development, as well as study design, conduct, analysis and reporting services.